Accessibility Menu
 
Summerset Group logo

Summerset Group

(ASX) SNZ

Current Price$7.40
Market Cap$1.86B
Since IPO (2013)+261%
5 Year-30%
1 Year-23%
1 Month-10%

Summerset Group Financials at a Glance

Market Cap

$1.86B

Revenue (TTM)

$679.50M

Net Income (TTM)

$599.58M

EPS (TTM)

$0.97

P/E Ratio

7.80

Dividend

$0.21

Beta (Volatility)

-0.07 (Low)

Price

$7.40

Volume

11,193

Open

$7.55

Previous Close

$7.40

Daily Range

$7.39 - $7.55

52-Week Range

$7.25 - $12.09

SNZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Summerset Group

Industry

Healthcare Providers and Services

Employees

2,290

CEO

Scott Grady Scoullar

Headquarters

Wellington, 6011, NZ

SNZ Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

36%

Net Income Margin

72%

Return on Equity

8%

Return on Capital

1%

Return on Assets

3%

Earnings Yield

12.82%

Dividend Yield

0.03%

Payout Ratio

12.55%

Stock Overview

Market Cap

$1.86B

Shares Outstanding

244.09M

Volume

11.19K

Short Interest

0.00%

Avg. Volume

2.42K

Financials (TTM)

Gross Profit

$272.07M

Operating Income

$5.92M

EBITDA

$299.52M

Operating Cash Flow

$446.98M

Capital Expenditure

$147.54M

Free Cash Flow

$299.45M

Cash & ST Invst.

$6.05M

Total Debt

$1.98B

Summerset Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$188.37M

+31.6%

Gross Profit

$141.32M

+266.1%

Gross Margin

75.02%

N/A

Market Cap

$1.86B

N/A

Market Cap/Employee

$605.85K

N/A

Employees

3,066

N/A

Net Income

$132.57M

-56.3%

EBITDA

$160.48M

+2230.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.98B

-43.7%

Accounts Receivable

$25.75M

-0.2%

Inventory

$0.00

N/A

Long Term Debt

$1.89B

+34.8%

Short Term Debt

$88.04M

+3457.0%

Return on Assets

2.81%

N/A

Return on Invested Capital

1.44%

N/A

Free Cash Flow

$195.65M

+8.9%

Operating Cash Flow

$268.73M

+29.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REG.AXRegis Healthcare Limited
$6.19-1.28%
NEU.AXNeuren Pharmaceuticals Limited
$12.52-0.48%
CU6.AXClarity Pharmaceuticals Ltd
$3.18+1.27%
NAN.AXNanosonics Limited
$3.72+1.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.78-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%

Questions About SNZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.